Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma

NCT03026998 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT03026998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03026998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI Screening of Second Primary Cancer Occurring Within Radiation Fields After Treatment by External Beam Radiation Therapy for Hereditary Retinoblastoma
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 19, 2017
Completion date
March 31, 2034
Enrollment
88 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary retinoblastoma